Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
002772 Tianshui Zhongxing Bio-technology
- 7.48
- +0.10+1.36%
Market Closed Apr 3 15:00 CST
2.94BMarket Cap22.94P/E (TTM)
7.51High7.33Low65.40KlotVolume7.37Open7.38Pre Close48.72MTurnover1.68%Turnover Ratio22.94P/E (Static)393.24MShares8.8052wk High0.89P/B2.92BFloat Cap5.5252wk Low8.12Limit Up390.14MShs Float30.21Historical High6.64Limit Down2.44%Amplitude5.06Historical Low0.30Dividend TTM7.45Avg Price27.44KlotAsk4.01%Div YieldTTM100Lot Size36.02KlotBid
Tianshui Zhongxing Bio-technology Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.21%1.94B | -2.48%1.42B | -10.22%914.68M | -21.87%486.7M | -1.99%1.93B | 0.53%1.45B | 18.64%1.02B | 27.60%622.91M | 26.61%1.97B | 36.43%1.44B |
| Operating revenue | 0.21%1.94B | -2.48%1.42B | -10.22%914.68M | -21.87%486.7M | -1.99%1.93B | 0.53%1.45B | 18.64%1.02B | 27.60%622.91M | 26.61%1.97B | 36.43%1.44B |
| Other operating revenue | 1,675.70%2.7M | ---- | --930.63K | ---- | --151.89K | ---- | --0 | ---- | --0 | ---- |
| Total operating cost | 2.72%1.84B | 4.02%1.35B | 7.82%894.19M | 8.66%458.25M | 0.57%1.79B | -1.24%1.29B | -3.89%829.31M | -2.09%421.72M | 17.12%1.78B | 19.09%1.31B |
| Operating cost | 3.02%1.53B | 4.45%1.14B | 8.09%752.64M | 10.14%389.5M | 1.24%1.49B | 0.15%1.09B | -2.44%696.28M | -1.13%353.63M | 15.82%1.47B | 17.78%1.09B |
| Operating tax surcharges | 24.21%3.67M | 15.72%2.46M | 20.42%1.73M | -19.38%564.91K | 3.07%2.95M | 3.85%2.12M | 10.02%1.44M | -5.04%700.74K | 19.96%2.87M | 26.32%2.05M |
| Operating expense | 1.47%158.34M | 1.42%116.11M | 0.99%76.59M | -1.80%39.06M | -2.46%156.04M | -2.74%114.48M | -1.89%75.84M | 1.09%39.78M | 21.26%159.97M | 24.18%117.7M |
| Administration expense | -0.89%84.63M | 8.22%49.14M | 7.93%34.2M | -4.04%16.7M | 3.76%85.39M | -6.47%45.41M | -9.33%31.68M | -1.33%17.4M | 7.11%82.29M | -5.45%48.55M |
| Financial expense | -1.94%46.93M | -7.15%31.29M | 21.80%22.06M | 15.29%8.51M | -17.15%47.86M | -28.06%33.7M | -41.65%18.11M | -42.38%7.38M | 64.46%57.76M | 86.29%46.84M |
| -Interest expense (Financial expense) | -8.08%76.85M | -1.98%56.54M | 1.71%37.79M | 24.69%17.09M | -7.60%83.61M | -18.10%57.69M | -26.49%37.15M | -45.15%13.7M | 11.90%90.49M | 19.37%70.44M |
| -Interest Income (Financial expense) | -8.65%-34.29M | -15.62%-25.94M | -29.01%-18.27M | -53.79%-8.44M | -1.87%-31.56M | 15.81%-22.43M | 35.66%-14.16M | 55.01%-5.49M | 42.19%-30.98M | 32.87%-26.65M |
| Research and development | 20.00%15.51M | 3.69%11.43M | 17.14%6.97M | 38.57%3.92M | 24.09%12.92M | 16.05%11.03M | 29.70%5.95M | 11.62%2.83M | 45.34%10.41M | 71.45%9.5M |
| Credit Impairment Loss | -191.12%-757.81K | -114.59%-108.71K | -73.26%232.11K | -87.66%32.29K | 183.81%831.65K | 164.12%745.1K | 204.79%868.07K | 127.91%261.64K | -779.71%-992.35K | -171.05%-1.16M |
| Asset Impairment Loss | -82.04%-13.08M | ---4.55M | ---875.45K | ---- | 47.80%-7.18M | ---- | --0 | ---- | ---13.76M | ---9.98M |
| Other net revenue | 54.59%30.98M | -9.88%15.97M | -20.58%6.86M | 376.55%5.87M | 191.13%20.04M | 289.49%17.72M | 185.60%8.64M | 94.99%-2.12M | -145.05%-21.99M | -202.15%-9.35M |
| Fair value change income | 244.10%15.22M | 155.38%4.99M | 66.81%-4.22M | 120.89%1.98M | 75.81%-10.56M | 56.25%-9.01M | 46.40%-12.7M | 80.20%-9.47M | -424.99%-43.64M | -51.69%-20.59M |
| Invest income | -12.93%12.89M | -83.17%1.7M | -70.83%2.83M | -143.96%-304.19K | 27.07%14.81M | 186.87%10.08M | 209.45%9.69M | 113.21%692.03K | 168.49%11.66M | -3.90%3.52M |
| -Including: Investment income associates | 368.90%8.77M | 15.52%-1.84M | -78.54%-709.28K | -190.96%-181.42K | -503.52%-3.26M | -512.91%-2.18M | -124.60%-397.26K | 186.19%199.45K | 91.68%-540.62K | 107.75%527.86K |
| Asset deal income | -26,621.03%-2.49M | -4,193.28%-385.05K | 299.28%44.04K | -17,987.07%-437.89K | -94.70%9.41K | -94.70%9.41K | -93.78%11.03K | -101.36%-2.42K | 726.24%177.39K | --177.39K |
| Other revenue | -13.25%19.2M | -9.82%14.33M | -17.85%8.85M | -28.02%4.6M | -9.95%22.13M | -14.94%15.89M | -3.23%10.77M | 8.51%6.39M | -20.52%24.58M | -4.19%18.68M |
| Operating profit | -21.21%125.21M | -51.18%85.68M | -86.20%27.34M | -82.76%34.32M | -4.37%158.92M | 40.84%175.49M | 1,499.07%198.18M | 1,217.49%199.06M | 99.36%166.19M | 483.27%124.61M |
| Add:Non operating Income | 176.07%2.78M | 186.49%2M | 579.62%1.74M | -9.04%111.49K | -24.49%1.01M | 17.98%698.28K | -31.91%256.57K | 2.86%122.58K | -40.48%1.34M | -28.42%591.89K |
| Less:Non operating expense | 273.64%1.4M | -60.48%126.63K | 65.62%481.99K | -81.75%27.39K | -95.66%374.06K | -95.12%320.41K | -95.56%291.03K | -85.63%150.06K | -72.43%8.63M | -63.50%6.57M |
| Total profit | -20.66%126.6M | -50.22%87.55M | -85.56%28.61M | -82.72%34.4M | 0.41%159.56M | 48.25%175.87M | 1,073.76%198.15M | 1,303.23%199.04M | 192.55%158.9M | 338.82%118.63M |
| Less:Income tax cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.06K | ---- |
| Net profit | -20.66%126.6M | -50.22%87.55M | -85.56%28.61M | -82.72%34.4M | 0.42%159.56M | 48.25%175.87M | 1,073.76%198.15M | 1,303.23%199.04M | 192.54%158.89M | 338.82%118.63M |
| Net profit from continuing operation | -20.66%126.6M | -50.22%87.55M | -85.56%28.61M | -82.72%34.4M | 0.42%159.56M | 48.25%175.87M | 1,073.76%198.15M | 1,303.23%199.04M | 192.54%158.89M | 338.82%118.63M |
| Less:Minority Profit | -5,475.69%-1.43M | -418.84%-1.1M | -229.23%-872.54K | -136.97%-345.03K | -104.73%-25.67K | 34.06%344.19K | 313.05%675.16K | 4,280.77%933.4K | 183.11%542.13K | 138.37%256.75K |
| Net profit of parent company owners | -19.77%128.03M | -49.49%88.65M | -85.07%29.48M | -82.46%34.75M | 0.78%159.58M | 48.28%175.53M | 1,085.80%197.48M | 1,298.75%198.1M | 188.08%158.35M | 341.56%118.38M |
| Earning per share | ||||||||||
| Basic earning per share | -16.52%0.3269 | -49.54%0.2254 | -85.08%0.075 | -82.47%0.0884 | -2.10%0.3916 | 46.22%0.4467 | 1,072.15%0.5026 | 1,277.60%0.5042 | 185.71%0.4 | 325.29%0.3055 |
| Diluted earning per share | -16.52%0.3269 | -49.54%0.2254 | -84.66%0.075 | -81.13%0.0884 | -2.10%0.3916 | 46.22%0.4467 | 1,045.65%0.4889 | 1,180.05%0.4685 | 185.71%0.4 | 325.29%0.3055 |
| Other composite income | ||||||||||
| Total composite income | -20.66%126.6M | -50.22%87.55M | -85.56%28.61M | -82.72%34.4M | 0.42%159.56M | 48.25%175.87M | 1,073.76%198.15M | 1,303.23%199.04M | 192.54%158.89M | 338.82%118.63M |
| Total composite income of parent company owners | -19.77%128.03M | -49.49%88.65M | -85.07%29.48M | -82.46%34.75M | 0.78%159.58M | 48.28%175.53M | 1,085.80%197.48M | 1,298.75%198.1M | 188.08%158.35M | 341.56%118.38M |
| Total composite income of minority owners | -5,475.69%-1.43M | -418.84%-1.1M | -229.23%-872.54K | -136.97%-345.03K | -104.73%-25.67K | 34.06%344.19K | 313.05%675.16K | 4,280.77%933.4K | 183.11%542.13K | 138.37%256.75K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.